MAX Chat
Share chart Viatris
Extended chart
Simple chart
Main settings
Currency
usd
Dividend income of JSC
5.45
Dividend of JSC
0.24
IPO Time
2020-11-16
ISIN
US92556V1061
Industry
Pharmaceuticals
Report Currency
usd
Sector
Health Care
Website
Grade
Underestimation
| Title | Value | Grade |
| P/S | 1 | 9 |
| P/BV | 0.7927 | 9 |
| P/E | -19.59 | 0 |
Efficiency
| Title | Value | Grade |
| ROA | -1.42 | 0 |
| ROE | -3.24 | 0 |
| ROIC | 1.21 | 1 |
Dividends
| Title | Value | Grade |
| Dividend yield | 5.11 | 10 |
| DSI | 1 | 10 |
| Average dividend growth | 20.64 | 10 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | 5.07 | 0 |
| Debt/Ratio | 0.3447 | 10 |
| Debt/Equity | 1.23 | 8 |
Growth impulse
| Title | Value | Grade |
| Revenue, bln, % | 23.38 | 4 |
| Ebitda, % | 41.5 | 6 |
| EPS, % | -52.12 | 0 |
Dividends
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 10.55 $ | 0 $ | 0 $ | -1.33 % | 0 % | 0 % |
| Week | 10.65 $ | 0 $ | 0 $ | -2.25 % | 0 % | 0 % |
| Month | 8.98 $ | 10.41 $ | 10.69 $ | +15.92 % | 0 % | 0 % |
| Three month | 8.85 $ | 8.74 $ | 10.69 $ | +17.63 % | 0 % | 0 % |
| Half a year | 7.56 $ | 7.26 $ | 10.69 $ | +37.7 % | 0 % | 0 % |
| Year | 12.8 $ | 7.26 $ | 13.37 $ | -18.67 % | 0 % | 0 % |
| 3 years | 10.96 $ | 7.26 $ | 13.53 $ | -5.02 % | 0 % | 0 % |
| 5 years | 15.24 $ | 7.26 $ | 18.74 $ | -31.69 % | 0 % | 0 % |
| 10 years | 39.16 $ | 7.26 $ | 55.28 $ | -73.42 % | 0 % | 0 % |
| Year to date | 11.48 $ | 7.26 $ | 12.45 $ | -9.32 % | 0 % | 0 % |
Insider trading
Main owners
Contained in ETF
ETF | Share, % | Profitability for 1 year, % | Commission, % |
| Future Tech ETF | 1.32059 | 479.5 | 0.35 |
| Principal Healthcare Innovators ETF | 1.32059 | -3.92 | 0.35 |
| iShares Morningstar Mid-Cap ETF | 0.12712 | 229.67 | 0.04 |
| iShares Morningstar Large-Cap Value ETF | 0.0532 | 50.52 | 0.25 |
| iShares Morningstar Large-Cap ETF | 0.02755 | 181.01 | 0.03 |
| Columbia U.S. ESG Equity Income ETF | 0.02437 | -3.61 | 0.35 |
| 0.48 | 155.53 | 0.23 |
|---|
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Mr. Paul B. Campbell | Chief Accounting Officer, Senior VP & Corporate Controller | N/A | 1968 (57 years) |
| Mr. Scott Andrew Smith | CEO & Director | N/A | 1962 (63 years) |
| Ms. Theodora Mistras | Chief Financial Officer | N/A | 1982 (43 years) |
| Mr. Brian S. Roman | Chief Legal Officer | 1971 (54 years) | |
| Mr. Ramkumar V. Rayapureddy | Chief Information Officer | ||
| Mr. Andrew Enrietti | Chief People Officer | ||
| Mr. Menassie Taddese M.B.A. | President of Emerging Markets | 1970 (55 years) | |
| Mr. Derek Glover | Chief Quality Officer | ||
| Ms. Lara Ramsburg | Chief Corporate Affairs Officer | ||
| Dr. Jeffrey Nau MMS, Ph.D. | President of Viatris Eye Care Division | 1976 (49 years) |
About company
Address: United States, Canonsburg. PA, 1000 Mylan Boulevard - Open in google maps, Open in yandex maps
Website: https://www.viatris.com
Website: https://www.viatris.com
